arginine vasopressin

Arginine vasopressin has four receptors, each of which are located in different tissues and have specific functions.

Arginine vasopressin receptor 1A is also known as:

V1bR acts as receptor for arginine vasopressin.

Arginine vasopressin receptor 2 is also expressed in the DCT.

Another example can be seen in diabetes insipidus, in which the kidneys become insensitive to arginine vasopressin.

Desmopressin is used to improve platelet function by activating arginine vasopressin receptor 1A.

C1QTNF1 has been shown to interact with Arginine vasopressin receptor 2.

CRH acts synergistically with arginine vasopressin, angiotensin II, and epinephrine.

Felypressin is a Vasopressin 1 agonist, and will thus have effects at all Arginine vasopressin receptor 1As.

NDI is a distinct disorder caused by complete or partial resistance of the kidneys to arginine vasopressin (AVP).

Desmopressin (1-desamino-8--arginine vasopressin) is a modified form of the normal human hormone arginine vasopressin, a peptide containing nine amino acids.

(In swine, which do not produce arginine vasopressin, lysine vasopressin acts synergistically with CRH.)

The hypothalamus, in turn, increases the production of vasopressin (ADH, AVP, or arginine vasopressin).

The mammalian gene product was originally discovered by expression cloning, due to the protein's ability to mobilize intracellular calcium in response to the peptide hormone arginine vasopressin.

In the kidney, AVPR2's primary function is to respond to arginine vasopressin by stimulating mechanisms that concentrate the urine and maintain water homeostasis in the organism.

This interaction takes place as Arginine Vasopressin works with corticotropin releasing hormone to stimulate the pituitary gland to secrete ACTH.

Renin-angiotensin axis is activated and arginine vasopressin (Anti-diuretic hormone; ADH) is released to conserve fluid via the kidneys.

The most common type in humans is central DI, caused by a deficiency of arginine vasopressin (AVP), also known as antidiuretic hormone (ADH).

Arginine vasopressin influences several symptoms related to affective disorders including significant memory processes, pain sensitivity, synchronization of biological rhythms and the timing and quality of REM sleep.

Sodium absorption is affected by the release of interleukin-6 as this can cause the secretion of arginine vasopressin which, in turn, can led to exercise-associated hyponatremia (dangerously low sodium levels).

Arginine vasopressin (AVP), also known as vasopressin, argipressin or antidiuretic hormone (ADH), is a neurohypophysial hormone found in most mammals.

This is in contrast to central/neurogenic diabetes insipidus, which is caused by insufficient levels of antidiuretic hormone (ADH)/Arginine Vasopressin (AVP).

Arginine vasopressin receptor 2 (officially abbreviated AVPR2) is a protein that acts as receptor for arginine vasopressin.

Background In golden hamsters, microinjections of arginine vasopressin (AVP) into the anterior hypothalamus trigger grooming and flank marking, a stereotyped scent marking behavior [ 1 2 ] .

In the human body, the steps that lead to the release of glucocorticoids such as cortisol begin with the release of corticotropin releasing hormone (CRH) and arginine vasopressin (AVP).